Berliner Boersenzeitung - Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

EUR -
AED 4.095102
AFN 72.480008
ALL 90.801688
AMD 402.807486
ANG 1.995737
AOA 1023.635334
ARS 1721.721299
AUD 1.61933
AWG 2.007127
AZN 1.900047
BAM 1.955836
BBD 2.250342
BDT 139.162586
BGN 1.948955
BHD 0.422108
BIF 3342.96213
BMD 1.115071
BND 1.431727
BOB 13.402249
BRL 6.138357
BSD 1.117321
BTN 104.873949
BWP 15.391286
BYN 3.345962
BYR 21855.38619
BZD 2.247142
CAD 1.573644
CDF 2586.964483
CHF 0.914162
CLF 0.027822
CLP 1094.980351
CNY 7.444774
CNH 7.438418
COP 3608.76707
CRC 506.709417
CUC 1.115071
CUP 26.815498
CVE 110.267049
CZK 24.346956
DJF 198.963698
DKK 7.480457
DOP 67.891262
DZD 151.940824
EGP 59.957114
ERN 16.726061
ETB 183.378708
FJD 2.526309
FKP 0.833961
GBP 0.834166
GEL 2.893653
GGP 0.833961
GHS 13.055243
GIP 0.833961
GMD 83.077063
GNF 9896.183924
GTQ 8.538159
GYD 234.234353
HKD 8.744429
HNL 30.029558
HRK 7.547925
HTG 146.432722
HUF 363.51345
IDR 20192.258205
ILS 3.552538
IMP 0.833961
INR 104.716854
IQD 1693.83148
IRR 2108992.359359
ISK 136.919964
JEP 0.833961
JMD 177.323296
JOD 0.790629
JPY 176.710877
KES 145.192698
KGS 97.510486
KHR 4552.084602
KMF 492.86165
KPW 1003.563608
KRW 1520.737678
KWD 0.346765
KYD 0.931217
KZT 500.809308
LAK 25136.46717
LBP 100053.859534
LKR 371.556906
LRD 189.94353
LSL 18.477643
LTL 3.292514
LVL 0.674496
LYD 7.150133
MAD 10.921803
MDL 19.971371
MGA 5077.094359
MKD 61.556144
MMK 2341.311039
MNT 4015.078679
MOP 9.019368
MRU 45.108838
MUR 52.442198
MVR 17.176258
MWK 1937.436008
MXN 20.766565
MYR 4.528864
MZN 71.257178
NAD 18.477643
NGN 1502.23485
NIO 41.120764
NOK 10.548462
NPR 167.798119
NZD 2.015128
OMR 0.428348
PAB 1.117421
PEN 3.848972
PGK 5.092095
PHP 70.369926
PKR 309.016043
PLN 4.399568
PYG 6984.129802
QAR 4.084276
RON 5.343646
RSD 117.622186
RUB 91.352798
RWF 1649.13065
SAR 4.188587
SBD 8.974739
SCR 15.358485
SDG 670.719139
SEK 11.033072
SGD 1.430306
SHP 0.835103
SLE 25.591287
SLL 23382.48045
SOS 638.511867
SRD 41.908265
STD 23079.712667
STN 24.500455
SVC 9.776182
SYP 14498.149201
SZL 18.471343
THB 37.411034
TJS 10.307092
TMT 3.902748
TND 3.343362
TOP 2.684822
TRY 55.9111
TTD 7.577141
TWD 36.546782
TZS 2952.454872
UAH 50.616941
UGX 4570.084937
USD 1.115071
UYU 44.950835
UZS 13332.247784
VES 999.456181
VND 28526.296796
VUV 133.25575
WST 3.108617
XAF 655.957
XAG 0.021465
XAU 0.000274244363
XCD 3.013535
XCG 2.013637
XDR 0.788413
XOF 655.957
XPF 119.331742
YER 263.853652
ZAR 18.420333
ZMK 10036.978597
ZMW 22.703422
ZWL 359.052318
SSP 6406.644798
MXV 2.33632
  • CMSD

    -0.1200

    19.81

    -0.61%

  • JRI

    0.0000

    10.77

    0%

  • BCC

    -1.8200

    74.15

    -2.45%

  • CMSC

    -0.2228

    19.53

    -1.14%

  • BCE

    0.2000

    20.34

    +0.98%

  • RIO

    0.0100

    94.17

    +0.01%

  • AZN

    -2.7400

    161.47

    -1.7%

  • GSK

    -1.1800

    48.17

    -2.45%

  • RBGPF

    0.0000

    65

    0%

  • NGG

    0.8800

    75.82

    +1.16%

  • RYCEF

    -0.7300

    19.08

    -3.83%

  • BTI

    -0.4500

    54.4

    -0.83%

  • BP

    0.4700

    43.99

    +1.07%

  • RELX

    -0.0600

    33.18

    -0.18%

  • VOD

    -0.1800

    16.15

    -1.11%

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries
Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

Akkodis and Biolevate Partner to Accelerate AI-Powered Scientific, Regulatory and Technical Documentation in Highly Regulated Industries

Partnership combines AI-powered scientific and regulatory documentation with expert oversight to accelerate productivity and compliance across life sciences, defense, aerospace and energy

Text size:

ZURICH, SWITZERLAND / ACCESS Newswire / September 29, 2026 / Akkodis, a global leader in digital engineering consulting and part of the Adecco Group, and Biolevate, an AI-powered life sciences company, today announced a strategic partnership to accelerate AI-assisted scientific, regulatory and technical documentation in highly regulated industries. Initially launching in France and Belgium, with plans for expansion into additional markets, the partnership combines Biolevate's AI platform with Akkodis' engineering, validation and regulatory expertise to help organizations improve compliance, reduce documentation burdens and accelerate innovation.

In highly regulated industries, scientific, technical and compliance-related documentation is critical to product approvals, quality, patient safety and operational compliance. As documentation volumes increase, organizations continue to struggle with manual, resource-intensive processes that are difficult to scale. The result is a pressing need for AI-assisted documentation solutions that improve productivity while maintaining compliance, traceability and expert oversight.

The partnership between Akkodis and Biolevate addresses these challenges by combining AI-powered automation with domain expertise and governed workflows purpose-built for regulated environments. Biolevate reports scientific literature reviews can be completed up to 2.5 times faster, while clinical study report generation and regulatory dossier preparation times can be reduced by up to 50% and MedTech development workflows by up to 30%.

A complementary alliance of technology and expertise

Akkodis brings deep expertise in life sciences, validation engineering, quality systems, regulatory compliance and AI transformation. The company helps organizations implement, validate and scale technology-enabled processes in complex, compliance-driven environments, bridging the gap between emerging technologies and real-world operations.

Biolevate provides ELISE, an AI-powered knowledge and workflow platform for regulated environments. Using natural language processing, computer vision and graph-based AI models, the platform helps organizations accelerate scientific writing, regulatory documentation and knowledge management workflows. Designed around controlled sources, traceable evidence, expert review processes and governed workflows, ELISE enables organizations to apply AI in a more consistent, transparent and auditable manner. The platform also helps organizations operationalize institutional knowledge through reusable templates, predefined methodologies and standardized review processes, enabling more consistent execution of documentation workflows across teams.

Unlike conversational AI tools, ELISE is designed around controlled sources, traceable evidence and governed workflows required for regulated processes.

The joint offering combines Biolevate's AI-powered knowledge and workflow platform with Akkodis' consulting, engineering, quality, validation and regulatory expertise to help customers deploy and scale AI-enabled documentation processes. Together, the companies help organizations operationalize AI across high-stakes scientific, regulatory and compliance workflows while maintaining transparency, traceability and expert oversight.

Use cases delivered at scale

The partnership supports high-value workflows across regulated environments, including:

  • Scientific Writing - Systematic literature reviews (SLRs), clinical study reports (CSRs) and scientific documentation.
  • Regulatory Documentation and Medical Communications - Regulatory dossiers, submissions, medical communications and regulatory intelligence workflows.
  • Validation Engineering and Commissioning & Qualification (C&Q) - Validation documentation, compliance reviews and audit-readiness activities.
  • Medical Device Development - Product development workflows supporting regulatory readiness and lifecycle management.

"This partnership reflects the core of Akkodis Intelligence: combining advanced AI with deep human expertise to modernize scientific, regulatory and technical documentation," said Jo Debecker, President and CEO of Akkodis. "Organizations in highly regulated industries need more than powerful AI models. They need governed workflows that support expert decision-making. Together, Akkodis and Biolevate help clients operationalize AI in ways that are scalable, traceable and aligned with regulatory requirements."

"Biolevate's mission is to pave the way for faster therapies by bringing innovation where it's most needed," said Joël Belafa, Co-founder and CEO of Biolevate. "Partnering with Akkodis enables scientists, engineers, and regulatory teams to redefine how they work in the AI era, boosting productivity, safeguarding critical knowledge, and bringing high-quality solutions to market faster. It is a major milestone for us to address this challenge at a much larger scale and Akkodis is recognized for the quality of their experts and their strategic impact on every continent."

- End -

Media contacts

Anne Friedrich
SVP, Global Head of Communications, Akkodis
M. +4915174633470
E. [email protected]

Lisa Bushka
VP, External Communications, Akkodis
M. +18604630770
E. [email protected]

About Akkodis

Akkodis is a global digital engineering consulting company that enables organizations to innovate and accelerate by applying technology to redefine how processes and products are developed, powered and optimized. With deep expertise across AI, data, cloud, edge and software engineering, we offer best-in-class technology consultancy. Through our strong, scalable delivery models and specialized talent, we provide end-to-end solutions, from strategy and consulting through implementation. Our commitment to Akkodis Intelligence helps businesses connect the exponential power of technology with the irreplaceable strengths of human thinking and collaboration. Part of the Adecco Group and headquartered in Switzerland, Akkodis brings together 40,000 engineers and digital experts in over 30 countries, with services that span Consulting, Solutions and Academy. With deep experience across the world's major industries, Akkodis empowers businesses to solve complex challenges and achieve sustainable impact. akkodis.com | LinkedIn | Instagram | Facebook | X

About the Adecco Group

The Adecco Group is the world's leading talent company. Our purpose is making the future work for everyone. Through our three global business units - Adecco, Akkodis and LHH - across 60 countries, we enable sustainable and lifelong employability for individuals, deliver digital and engineering solutions to power transformation and empower organisations to optimise their workforces. The Adecco Group leads by example and is committed to an inclusive culture, fostering sustainable employability, and supporting resilient economies and communities. The Adecco Group AG is headquartered in Zurich, Switzerland (ISIN: CH0012138605) and listed on the SIX Swiss Exchange (ADEN). www.adeccogroup.com

About Biolevate

Biolevate is an AI-native technology company helping life sciences organizations turn complex scientific, operational and regulatory knowledge into reliable, repeatable workflows. Its platform processes documents and data across multiple formats, connects knowledge from diverse sources and coordinates specialized AI agents to support research, evidence reviews, scientific and regulatory writing, quality, manufacturing, safety and knowledge management. Biolevate enables organizations to use AI at scale with greater transparency, consistency and accountability, reducing manual work and accelerating critical processes from discovery to patients. The company supports organizations across the pharmaceutical value chain, including Sanofi and Merck/MSD, and is backed by leading investors including EQT Ventures and Orange Ventures.

www.biolevate.com | LinkedIn

SOURCE: Akkodis



View the original press release on ACCESS Newswire

(K.Lüdke--BBZ)